Autolysosomes and caspase-3 control the biogenesis and release of immunogenic apoptotic exosomes.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
11 02 2022
Historique:
received: 16 07 2021
accepted: 27 01 2022
revised: 04 01 2022
entrez: 12 2 2022
pubmed: 13 2 2022
medline: 9 4 2022
Statut: epublish

Résumé

Apoptotic exosome-like vesicles (ApoExos) are a novel type of extracellular vesicle that contribute to the propagation of inflammation at sites of vascular injury when released by dying cells. ApoExos are characterized by the presence of the C-terminal perlecan LG3 fragment and 20S proteasome, and they are produced downstream of caspase-3 activation. In the present study, we assessed the relative roles of autophagy and caspase-3-mediated pathways in controlling the biogenesis and secretion of immunogenic ApoExos. Using electron microscopy and confocal immunofluorescence microscopy in serum-starved endothelial cells, we identified large autolysosomes resulting from the fusion of lysosomes, multivesicular bodies, and autophagosomes as a site of ApoExo biogenesis. Inhibition of autophagy with ATG7 siRNA or biochemical inhibitors (wortmannin and bafilomycin) coupled with proteomics analysis showed that autophagy regulated the processing of perlecan into LG3 and its loading onto ApoExos but was dispensable for ApoExo biogenesis. Caspase-3 activation was identified using caspase-3-deficient endothelial cells or caspase inhibitors as a pivotal regulator of fusion events between autolysosomes and the cell membrane, therefore regulating the release of immunogenic ApoExos. Collectively, these findings identified autolysosomes as a site of ApoExo biogenesis and caspase-3 as a crucial regulator of autolysosome cell membrane interactions involved in the secretion of immunogenic ApoExos.

Identifiants

pubmed: 35149669
doi: 10.1038/s41419-022-04591-5
pii: 10.1038/s41419-022-04591-5
pmc: PMC8837616
doi:

Substances chimiques

Caspase 3 EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

145

Subventions

Organisme : Gouvernement du Canada | Instituts de Recherche en Santé du Canada | Institute of Nutrition, Metabolism and Diabetes (Institut de la Nutrition, du Métabolisme et du Diabète)
ID : MOP-15447
Organisme : Gouvernement du Canada | Instituts de Recherche en Santé du Canada | Institute of Nutrition, Metabolism and Diabetes (Institut de la Nutrition, du Métabolisme et du Diabète)
ID : PJT-148884

Informations de copyright

© 2022. The Author(s).

Références

Kimura T, Jia J, Kumar S, Choi SW, Gu Y, Mudd M, et al. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J. 2017;36:42–60.
pubmed: 27932448 doi: 10.15252/embj.201695081
Iula L, Keitelman IA, Sabbione F, Fuentes F, Guzman M, Galletti JG, et al. Autophagy mediates interleukin-1beta secretion in human neutrophils. Front Immunol. 2018;9:269.
pubmed: 29515581 pmcid: 5825906 doi: 10.3389/fimmu.2018.00269
Sirois I, Groleau J, Pallet N, Brassard N, Hamelin K, Londono I, et al. Caspase activation regulates the extracellular export of autophagic vacuoles. Autophagy. 2012;8:927–37.
pubmed: 22692030 pmcid: 3427258 doi: 10.4161/auto.19768
Kowal J, Tkach M, Thery C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014;29:116–25.
pubmed: 24959705 doi: 10.1016/j.ceb.2014.05.004
Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164:1226–32.
pubmed: 26967288 doi: 10.1016/j.cell.2016.01.043
Wang X, Xu M, Jia J, Zhang Z, Gaut JP, Upadhya GA, et al. CD47 blockade reduces ischemia/reperfusion injury in donation after cardiac death rat kidney transplantation. Am J Transplant. 2018;18:843–54.
pubmed: 28975767 doi: 10.1111/ajt.14523
Leidal AM, Huang HH, Marsh T, Solvik T, Zhang D, Ye J, et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol. 2020;22:187–99.
pubmed: 31932738 pmcid: 7007875 doi: 10.1038/s41556-019-0450-y
Li M, Gao P, Zhang J. Crosstalk between autophagy and apoptosis: potential and emerging therapeutic targets for cardiac diseases. Int J Mol Sci. 2016;17:332.
pubmed: 26950124 pmcid: 4813194 doi: 10.3390/ijms17030332
El-Khattouti A, Selimovic D, Haikel Y, Hassan M. Crosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer. J Cell Death. 2013;6:37–55.
pubmed: 25278778 pmcid: 4147769 doi: 10.4137/JCD.S11034
Dieude M, Bell C, Turgeon J, Beillevaire D, Pomerleau L, Yang B, et al. The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection. Sci Transl Med. 2015;7:318ra200.
pubmed: 26676607 doi: 10.1126/scitranslmed.aac9816
Dieude M, Turgeon J, Rimbaud AK, Beillevaire D, Qi S, Patey N, et al. Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts. Am J Transplant. 2020;20:726–38.
pubmed: 31729155 doi: 10.1111/ajt.15707
Cardinal H, Dieude M, Brassard N, Qi S, Patey N, Soulez M, et al. Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury. Am J Transplant. 2013;13:861–74.
pubmed: 23432943 doi: 10.1111/ajt.12168
Yang B, Dieude M, Hamelin K, Henault-Rondeau M, Patey N, Turgeon J, et al. Anti-LG3 antibodies aggravate renal ischemia-reperfusion injury and long-term renal allograft dysfunction. Am J Transplant. 2016;16:3416–29.
pubmed: 27172087 doi: 10.1111/ajt.13866
Pilon EA, Dieude M, Qi S, Hamelin K, Pomerleau L, Beillevaire D, et al. The perlecan fragment LG3 regulates homing of mesenchymal stem cells and neointima formation during vascular rejection. Am J Transplant. 2015;15:1205–18.
pubmed: 25808553 doi: 10.1111/ajt.13119
Pallet N, Sirois I, Bell C, Hanafi LA, Hamelin K, Dieude M, et al. A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics. 2013;13:1108–20.
pubmed: 23436686 doi: 10.1002/pmic.201200531
Migneault F, Dieudé M, Turgeon J, Beillevaire D, Hardy MP, Brodeur A, et al. Apoptotic exosome-like vesicles regulate endothelial gene expression, inflammatory signaling, and function through the NF-κB signaling pathway. Sci Rep. 2020;10:12562.
pubmed: 32724121 pmcid: 7387353 doi: 10.1038/s41598-020-69548-0
Hardy MP, Audemard É, Migneault F, Feghaly A, Brochu S, Gendron P, et al. Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs. Sci Rep. 2019;9:7203.
pubmed: 31076589 pmcid: 6510763 doi: 10.1038/s41598-019-43591-y
Rousseau M, Belleannee C, Duchez AC, Cloutier N, Levesque T, Jacques F, et al. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS ONE. 2015;10:e0116812.
pubmed: 25587983 pmcid: 4294685 doi: 10.1371/journal.pone.0116812
Marcoux G, Duchez AC, Cloutier N, Provost P, Nigrovic PA, Boilard E. Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses. Sci Rep. 2016;6:35928.
pubmed: 27786276 pmcid: 5081512 doi: 10.1038/srep35928
Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood. 2014;124:2173–83.
pubmed: 25082876 pmcid: 4260364 doi: 10.1182/blood-2014-05-573543
Soulez M, Sirois I, Brassard N, Raymond MA, Nicodeme F, Noiseux N, et al. Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells. Stem Cells. 2010;28:810–20.
pubmed: 20201065 doi: 10.1002/stem.403
Nafar M, Sahraei Z, Salamzadeh J, Samavat S, Vaziri ND. Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. Iran J Kidney Dis. 2011;5:357–72.
pubmed: 22057066
Cailhier JF, Sirois I, Laplante P, Lepage S, Raymond MA, Brassard N, et al. Caspase-3 activation triggers extracellular cathepsin L release and endorepellin proteolysis. J Biol Chem. 2008;283:27220–9.
pubmed: 18658137 doi: 10.1074/jbc.M801164200
Dragun D, Muller DN, Brasen JH, Fritsche L, Nieminen-Kelha M, Dechend R, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005;352:558–69.
pubmed: 15703421 doi: 10.1056/NEJMoa035717
Joosten SA, Sijpkens YW, van Ham V, Trouw LA, van der Vlag J, van den Heuvel B, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant. 2005;5:383–93.
pubmed: 15643999 doi: 10.1111/j.1600-6143.2005.00690.x
Jurcevic S, Ainsworth ME, Pomerance A, Smith JD, Robinson DR, Dunn MJ, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation. 2001;71:886–92.
pubmed: 11349721 doi: 10.1097/00007890-200104150-00011
Jackson AM, Sigdel TK, Delville M, Hsieh SC, Dai H, Bagnasco S, et al. Endothelial cell antibodies associated with novel targets and increased rejection. J Am Soc Nephrol. 2015;26:1161–71.
pubmed: 25381426 doi: 10.1681/ASN.2013121277
Banasik M, Boratynska M, Koscielska-Kasprzak K, Krajewska M, Mazanowska O, Kaminska D, et al. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes. Transpl Immunol. 2014;30:24–9.
pubmed: 24184747 doi: 10.1016/j.trim.2013.10.007
Cardinal H, Dieudé M, Hébert MJ. The emerging importance of non-HLA autoantibodies in kidney transplant complications. J Am Soc Nephrol. 2017;28:400–6.
pubmed: 27798244 doi: 10.1681/ASN.2016070756
See SB, Aubert O, Loupy A, Veras Y, Lebreton X, Gao B, et al. Post-transplant natural antibodies associate with kidney allograft injury and reduced long-term survival. J Am Soc Nephrol. 2018;29:1761–70.
pubmed: 29602833 pmcid: 6054349 doi: 10.1681/ASN.2017111157
Porcheray F, Fraser JW, Gao B, McColl A, DeVito J, Dargon I, et al. Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement. Am J Transplant. 2013;13:2590–600.
pubmed: 23919437 doi: 10.1111/ajt.12394
Tucher C, Bode K, Schiller P, Claßen L, Birr C, Souto-Carneiro MM, et al. Extracellular vesicle subtypes released from activated or apoptotic T-lymphocytes carry a specific and stimulus-dependent protein cargo. Front Immunol. 2018;9:534.
pubmed: 29599781 pmcid: 5862858 doi: 10.3389/fimmu.2018.00534
Subramani S, Malhotra V. Non-autophagic roles of autophagy-related proteins. EMBO Rep. 2013;14:143–51.
pubmed: 23337627 pmcid: 3566844 doi: 10.1038/embor.2012.220
Urano Y, Mori C, Fuji A, Konno K, Yamamoto T, Yashirogi S, et al. 6-Hydroxydopamine induces secretion of PARK7/DJ-1 via autophagy-based unconventional secretory pathway. Autophagy. 2018;14:1943–58.
pubmed: 30112966 pmcid: 6152502 doi: 10.1080/15548627.2018.1493043
Deretic V, Jiang S, Dupont N. Autophagy intersections with conventional and unconventional secretion in tissue development, remodeling and inflammation. Trends Cell Biol. 2012;22:397–406.
pubmed: 22677446 pmcid: 3408825 doi: 10.1016/j.tcb.2012.04.008
Endo S, Nakata K, Ohuchida K, Takesue S, Nakayama H, Abe T, et al. Autophagy is required for activation of pancreatic stellate cells, associated with pancreatic cancer progression and promotes growth of pancreatic tumors in mice. Gastroenterology. 2017;152:1492–506.e24.
pubmed: 28126348 doi: 10.1053/j.gastro.2017.01.010
Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. Embo J. 2011;30:4701–11.
pubmed: 22068051 pmcid: 3243609 doi: 10.1038/emboj.2011.398
Wang Z, Zhou H, Zheng H, Zhou X, Shen G, Teng X, et al. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation. Autophagy. 2021;17:529–52.
pubmed: 32019420 doi: 10.1080/15548627.2020.1725381
Nüchel J, Ghatak S, Zuk AV, Illerhaus A, Mörgelin M, Schönborn K, et al. TGFB1 is secreted through an unconventional pathway dependent on the autophagic machinery and cytoskeletal regulators. Autophagy. 2018;14:465–86.
pubmed: 29297744 pmcid: 5915026 doi: 10.1080/15548627.2017.1422850
Buratta S, Tancini B, Sagini K, Delo F, Chiaradia E, Urbanelli L, et al. Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic- and endo-lysosomal systems go extracellular. Int J Mol Sci. 2020;21:2576.
pmcid: 7178086 doi: 10.3390/ijms21072576
Machado E, White-Gilbertson S, van de Vlekkert D, Janke L, Moshiach S, Campos Y, et al. Regulated lysosomal exocytosis mediates cancer progression. Sci Adv. 2015;1:e1500603.
pubmed: 26824057 pmcid: 4730843 doi: 10.1126/sciadv.1500603
Kim MS, Muallem S, Kim SH, Kwon KB, Kim MS. Exosomal release through TRPML1-mediated lysosomal exocytosis is required for adipogenesis. Biochem Biophys Res Commun. 2019;510:409–15.
pubmed: 30711251 doi: 10.1016/j.bbrc.2019.01.115
Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annu Rev Cell Dev Biol. 2016;32:255–78.
pubmed: 27298091 pmcid: 6490169 doi: 10.1146/annurev-cellbio-111315-125407
Lee C, Lamech L, Johns E, Overholtzer M. Selective lysosome membrane turnover is induced by nutrient starvation. Dev Cell. 2020;55:289–97.e4.
pubmed: 32916093 pmcid: 8337093 doi: 10.1016/j.devcel.2020.08.008
Olsvik HL, Svenning S, Abudu YP, Brech A, Stenmark H, Johansen T, et al. Endosomal microautophagy is an integrated part of the autophagic response to amino acid starvation. Autophagy. 2019;15:182–3.
pubmed: 30295124 doi: 10.1080/15548627.2018.1532265
Lorey MB, Rossi K, Eklund KK, Nyman TA, Matikainen S. Global characterization of protein secretion from human macrophages following non-canonical Caspase-4/5 inflammasome activation. Mol Cell Proteom. 2017;16 4 Suppl 1:S187–99.
doi: 10.1074/mcp.M116.064840
Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, et al. Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. 2016;64:651–60.
pubmed: 26632633 doi: 10.1016/j.jhep.2015.11.020

Auteurs

Déborah Beillevaire (D)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.
Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada.
Département de Médecine, Université de Montréal, Montréal, QC, Canada.

Francis Migneault (F)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.
Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada.

Julie Turgeon (J)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.
Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada.

Diane Gingras (D)

Département de Pathologie et Biologie Cellulaire, Université de Montréal, Montréal, QC, Canada.

Annie Karakeussian Rimbaud (AK)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.
Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada.

Geneviève Marcoux (G)

Département de Microbiologie et Immunologie, Centre de Recherche, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, QC, Canada.

Crysta Spino (C)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.

Nicolas Thibodeau (N)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.

Eric Bonneil (E)

Institute for Research in Immunology and Cancer (IRIC), Montréal, QC, Canada.

Pierre Thibault (P)

Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada.
Institute for Research in Immunology and Cancer (IRIC), Montréal, QC, Canada.

Éric Boilard (É)

Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada.
Département de Microbiologie et Immunologie, Centre de Recherche, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval, Québec, QC, Canada.

Mélanie Dieudé (M)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada.
Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada.

Marie-Josée Hébert (MJ)

Centre de Recherche, Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Montréal, QC, Canada. marie-josee.hebert@umontreal.ca.
Canadian Donation and Transplantation Research Program (CDTRP), Edmonton, AL, Canada. marie-josee.hebert@umontreal.ca.
Département de Médecine, Université de Montréal, Montréal, QC, Canada. marie-josee.hebert@umontreal.ca.

Articles similaires

Animals Dogs Dog Diseases Autophagy Immunohistochemistry
Humans RNA, Circular Exosomes Cell Proliferation Epithelial-Mesenchymal Transition
Humans Formins Phosphorylation Exosomes Jurkat Cells
Animals Humans TOR Serine-Threonine Kinases Lupus Erythematosus, Systemic Arthritis, Rheumatoid

Classifications MeSH